Rating History for Enliven Therapeutics (ELVN) by Stifel

More Stocks Rated by Stifel | Latest Ratings for ELVN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/8/2026 Dara Azar New Coverage Buy
(N/A)		 60.00
(N/A)		 34.71
(48.60)		 40.02% Details